BioRestorative Therapies, Inc. SEC filings BRTX

BioRestorative Therapies, Inc. has 754 filings in SEC EDGAR's recent list, going back to Nov 16, 2010. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change). The company's fiscal year ends on December 31.

BioRestorative Therapies, Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Apr 30, 2026 —
POS AM Filing Apr 27, 2026 —
POS AM Filing Apr 20, 2026 —
424B4 Prospectus Feb 13, 2026 —
S-1/A Amended registration statement Feb 10, 2026 —
S-1 Registration statement Feb 9, 2026 —
424B3 Prospectus Dec 12, 2025 —
S-8 Employee stock plan registration Nov 18, 2025 —
S-1 Registration statement Nov 18, 2025 —
424B5 Prospectus supplement Oct 8, 2025 —
424B5 Prospectus supplement Oct 6, 2025 —
S-8 Employee stock plan registration Nov 13, 2024 —
424B5 Prospectus supplement Nov 6, 2024 —
424B3 Prospectus Apr 19, 2024 —
S-1/A Amended registration statement Apr 12, 2024 —
S-1 Registration statement Apr 3, 2024 —
S-8 Employee stock plan registration Nov 15, 2023 —
424B5 Prospectus supplement Aug 23, 2023 —
424B5 Prospectus supplement Jul 13, 2023 —
424B5 Prospectus supplement Jul 11, 2023 —
424B5 Prospectus supplement May 15, 2023 —
424B2 Prospectus Apr 14, 2023 —
S-8 Employee stock plan registration Mar 28, 2023 —
S-3/A Amendment 1 Feb 13, 2023 —
S-3 Shelf registration Feb 7, 2023 —
POS AM Amendment 1 to post effective amendment 1 to form s-1 on form s-3 Sep 30, 2022 —
POS AM Post-effective amendment no. 1 to form s-1 on form s-3 Aug 16, 2022 —
424B3 Prospectus Jun 23, 2022 —
S-3 Shelf registration May 18, 2022 —
424B4 Prospectus Nov 9, 2021 —
S-1MEF Filing Nov 4, 2021 —
S-1/A Amended registration statement Nov 4, 2021 —
S-1/A Amended registration statement Oct 29, 2021 —
S-1/A Amended registration statement Oct 18, 2021 —
S-1 Registration statement Aug 6, 2021 —
S-8 Employee stock plan registration Apr 30, 2021 —
S-1/A Amended registration statement Sep 6, 2019 —
S-8 Employee stock plan registration Aug 15, 2019 —
S-1 Registration statement Apr 26, 2019 —
S-8 Employee stock plan registration Nov 16, 2018 —
FWP Free writing prospectus Oct 6, 2017 —
S-1 Registration statement Oct 5, 2017 —
S-8 Employee stock plan registration Nov 15, 2016 —
S-8 Employee stock plan registration Apr 1, 2016 —
424B4 Prospectus Dec 2, 2015 —
S-1/A Amended registration statement Nov 5, 2015 —
S-1/A Amended registration statement Oct 27, 2015 —
FWP Free writing prospectus Oct 19, 2015 —
S-1/A Amended registration statement Oct 16, 2015 —
FWP Free writing prospectus Sep 28, 2015 —
S-1/A Amended registration statement Sep 25, 2015 —
S-1 Registration statement Jun 3, 2015 —
S-8 Employee stock plan registration Apr 9, 2015 —
S-8 Employee stock plan registration May 27, 2014 —

Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
BRTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Melville, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1505497
Former names
Stem Cell Assurance, Inc. (until Aug 16, 2011)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.